Results 231 to 240 of about 145,467 (273)
Micellar Liquid Chromatography Determination of Edoxaban in Oral Solid Dosage Forms: Theoretical Aspects and Validation
ChemMedChem, Volume 20, Issue 22, November 18, 2025.A method is developed and validated to quantify edoxaban in solid oral dosage forms using micellar liquid chromatography. A chemometric strategy is used to study the retention mechanism. The procedure is green, economic, safe, and easy to handle; offers high sample throughput; and is reliable, thus useful for pharmaceutical quality control.Juan Peris‐Vicente, Devasish Bose, Rajendra‐Pasad Pawar, Abhilasha Durgbanshi, Samuel Carda‐Broch +4 morewiley +1 more sourceReal-world comparison of major bleeding risk among non-valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban, or warfarin
Thrombosis and Haemostasis, 2016 G. Lip, A. Keshishian, S. Kamble, Xianying Pan, J. Mardekian, R. Horblyuk, M. Hamilton +6 moresemanticscholar +1 more sourceEffect of VKORC1 haplotypes on transcriptional regulation and warfarin dose.
New England Journal of Medicine, 2005 M. Rieder, A. Reiner, B. Gage, D. Nickerson, C. Eby, H. McLeod, D. Blough, K. Thummel, D. Veenstra, A. Rettie +9 moresemanticscholar +1 more sourceExtended use of dabigatran, warfarin, or placebo in venous thromboembolism.
New England Journal of Medicine, 2013 S. Schulman, C. Kearon, A. Kakkar, S. Schellong, H. Eriksson, David Baanstra, A. M. Kvamme, J. Friedman, P. Mismetti, S. Goldhaber +9 moresemanticscholar +1 more sourceRisk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation: An Analysis of the Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY) Trial
Circulation, 2011 J. Eikelboom, L. Wallentin, Stuart J. Connolly, M. Ezekowitz, Jeff S. Healey, Jonas Oldgren, Sean Yang, M. Alings, Scott Kaatz, S. Hohnloser, Hans-Christoph Diener, M. Franzosi, Kurt Huber, P. Reilly, Jeanne Varrone, Salim Yusuf +15 moresemanticscholar +1 more sourceGut Microbiome Diversity and Composition Correlates With Time in the Therapeutic Range in Patients on Warfarin Treatment: A Pilot Study
Pasquale Agosti, Afroditi Kouraki, Tommaso Dionisi, Giovanni Addolorato, Luca D’Innocenzo, Silvia Sorrentino, Flavio De Maio, Erica De Candia, Aitor Blanco‐Míguez, Davide Bazzani, Angela Bonadiman, Guendalina Tonidandel, Mattia Bolzan, Francesca Gianniello, Serena M. Passamonti, Maria Abbattista, Ana M. Valdes, Paolo Bucciarelli, Flora Peyvandi, Cristina Menni +19 moreopenalex +2 more sources
